Lead Product(s) : Podophyllotoxin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Hyloris Announces US FDA Approval for Podofilox Gel
Details : FDA approved ANDA for Podofilox Gel, a tubulin binder causing cell mitotic arrest, making it ththe first generic topical drug product for the treatment of external genital and perianal warts.
Product Name : Condylox-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 04, 2023
Lead Product(s) : Podophyllotoxin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Podophyllotoxin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Biorasi
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Podofilox is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Condylomata Acuminata.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 22, 2018
Lead Product(s) : Podophyllotoxin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Biorasi
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
